Ceftriaxone (Ro 13-9904) therapy of serious infection.
Ceftriaxone (Ro 13-9904), a newly developed cephalosporin with a long half-life, was evaluated for efficacy and safety in 19 patients with serious infections. Underlying illnesses were present in 16 patients. Ceftriaxone was given intravenously every 12 h. Infections treated included gram-negative b...
Na minha lista:
| Udgivet i: | Antimicrob Agents Chemother |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Microbiology (ASM)
1982
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC183670/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6289739/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.22.1.36 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|